All Episodes

November 23, 2022 45 mins

Greg Bogart, PharmD, BCPP, discusses his passion for Movember, a charity that raises awareness for men's mental health, testicular cancer, and prostate cancer.  Greg teaches psychiatry and pharmacy residents about psychopharmacology. We share our thoughts on how men's completion of suicide differs from other genders. Greg shares about side effects of typical antidepressant treatment. We discuss male mental health challenges and how testosterone is used and misused. We talk about challenging topics that frequently are unique to males, like mass shootings and sexual predators. #Movember #mensmentalhealth #psychopharmacology #psychiatry #pharmacy #pharmacist #residency #sideeffects 

Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

The Male Room with Dr. Jesse Mills

The Male Room with Dr. Jesse Mills

As Director of The Men’s Clinic at UCLA, Dr. Jesse Mills has spent his career helping men understand their bodies, their hormones, and their health. Now he’s bringing that expertise to The Male Room — a podcast where data-driven medicine meets common sense. Each episode separates fact from hype, science from snake oil, and gives men the tools to live longer, stronger, and happier lives. With candor, humor, and real-world experience from the exam room and the operating room, Dr. Mills breaks down the latest health headlines, dissects trends, and explains what actually works — and what doesn’t. Smart, straightforward, and entertaining, The Male Room is the show that helps men take charge of their health without the jargon.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.